| Literature DB >> 34057805 |
Mehdi Maanaoui1,2, Dulciane Baes1, Aghilès Hamroun1,3, Kahina Khedjat1, Fanny Vuotto4, Emmanuel Faure4, Benjamin Lopez5, Sébastien Bouyé6, Thomas Caes6, Arnaud Lionet1, Céline Lebas1, François Provôt1, François Glowacki1, Jean-Baptiste Gibier7, Rémi Lenain1, Marc Hazzan1.
Abstract
The association between acute graft pyelonephritis (AGPN) and graft failure in kidney transplant recipients (KTR) remains controversial. In this single-center observational study, we aimed to assess the incidence of AGPN as a time-dependent post-transplantation event. We also examined the association between the diagnosis of AGPN and graft outcomes. In total, we evaluated 1480 patients who underwent kidney transplantation between January 2007 and December 2017. During a median follow-up of 5.04 years, we observed 297 AGPN episodes that occurred in 158 KTR. To evaluate the association between AGPN and clinical outcomes, we performed Cox proportional hazards regression analyses in which AGPN was entered as a time-dependent covariate. AGPN was independently associated with an increased risk of graft loss (hazard ratio = 1.66; 95% confidence interval [CI]: 1.05-2.64, p<0.03) and a persistently decreased eGFR (fixed effect on intercept: -2.29 mL/min/1.73 m²; 95% CI: from -3.23 to -1.35, p<0.01). However, neither mortality nor biopsy-proven acute rejection was found to correlate with AGPN. Moreover, recurrent AGPN episodes did not appear to have an additive detrimental impact on graft loss. These data represent a promising step in understanding whether AGPN prevention may decrease the risk of graft loss in KTR. This article is protected by copyright. All rights reserved.Entities:
Year: 2021 PMID: 34057805 DOI: 10.1111/ajt.16703
Source DB: PubMed Journal: Am J Transplant ISSN: 1600-6135 Impact factor: 8.086